Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1993 | 03-1993 | 12-1992 | 09-1992 | 06-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,257 | 5,575 | 6,060 | 780 | 1,354 |
| Receivables | 314 | 113 | 251 | 3,785 | 658 |
| Other current assets | 95 | 74 | 116 | 14 | 38 |
| TOTAL | $4,666 | $5,761 | $6,427 | $4,579 | $2,051 |
| Non-Current Assets | |||||
| PPE Net | 117 | 142 | 138 | 96 | 132 |
| Other Non-Current Assets | 20 | 20 | 20 | 24 | 24 |
| TOTAL | $137 | $162 | $158 | $120 | $157 |
| Total Assets | $4,744 | $5,869 | $6,534 | $4,654 | $2,169 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 300 | 197 | 319 | 307 | 383 |
| Accrued Expenses | 255 | 571 | 612 | 258 | 347 |
| Other current liabilities | 46 | 50 | 78 | 0 | 0 |
| TOTAL | $601 | $817 | $1,009 | $565 | $729 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $601 | $817 | $1,009 | $565 | $729 |
| Shareholders' Equity | |||||
| Common Shares | 335 | 335 | 333 | 331 | 329 |
| Retained earnings | -36,139 | -35,219 | -34,841 | -36,167 | -38,670 |
| Other shareholders' equity | -5 | -4 | -5 | -5 | -5 |
| TOTAL | $4,143 | $5,052 | $5,525 | $4,089 | $1,440 |
| Total Liabilities And Equity | $4,744 | $5,869 | $6,534 | $4,654 | $2,169 |